{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:27:52Z","timestamp":1792168072300,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2012,10,2]]},"DOI":"10.1212\/wnl.0b013e31826d5fc3","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T22:59:39Z","timestamp":1348095579000},"page":"1499-1506","source":"Crossref","is-referenced-by-count":159,"title":["Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease"],"prefix":"10.1212","volume":"79","author":[{"given":"Taim","family":"Muayqil","sequence":"first","affiliation":[{"name":"From the King Saud University (T.M.), Riyadh, Saudi Arabia; University of Kansas Medical Center (G.G.), Kansas City; and University of Alberta (R.C.), Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gronseth","sequence":"additional","affiliation":[{"name":"From the King Saud University (T.M.), Riyadh, Saudi Arabia; University of Kansas Medical Center (G.G.), Kansas City; and University of Alberta (R.C.), Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Camicioli","sequence":"additional","affiliation":[{"name":"From the King Saud University (T.M.), Riyadh, Saudi Arabia; University of Kansas Medical Center (G.G.), Kansas City; and University of Alberta (R.C.), Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000160117.56690.B2"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2008.533"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000184674.32924.c9"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000230159.67128.00"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl159"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.6.813"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.9.1210"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000135153.96325.3B"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430109"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.728"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609263351303"},{"key":"e_1_3_9_14_2","volume-title":"Physiological and Biochemical Aspects of Nervous Integration","author":"Moore BW","year":"1967","unstructured":"Moore BW, Perez VJ . Specific acidic proteins of the nervous systems. In: Physiological and Biochemical Aspects of Nervous Integration. Englewood Cliffs, NJ: Prentice Hall; 1967."},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)97483-1"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb07927.x"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.40.1.617"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(95)00022-4"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(00)00519-4"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.032037"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.811"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410050212"},{"key":"e_1_3_9_23_2","article-title":"WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease","author":"Brown P","year":"2003","unstructured":"Brown P, Budka H, Cervenakova L , et al. . WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. World Health Organization, Communicable Disease Surveillance and Response; 2003.","journal-title":"World Health Organization, Communicable Disease Surveillance and Response"},{"key":"e_1_3_9_24_2","first-page":"1147","article-title":"Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease","volume":"16","author":"Blennow K","year":"2005","unstructured":"Blennow K, Johansson A, Zetterberg H . Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Int J Mol Med 2005; 16: 1147\u2013 1149 .","journal-title":"Int J Mol Med"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.5.1095"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.2.192"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1054\/jocn.1999.0193"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017095"},{"key":"e_1_3_9_29_2","volume-title":"Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice","author":"Richardson WS","year":"2008","unstructured":"Richardson WS, Wilson MC . The process of diagnosis. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 2nd ed. New York, NY: McGraw-Hill; 2008.","edition":"2"},{"key":"e_1_3_9_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21430"},{"key":"e_1_3_9_31_2","first-page":"1551","article-title":"Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis","volume":"26","author":"Young GS","year":"2005","unstructured":"Young GS, Geschwind MD, Fischbein NJ , et al. . Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26: 1551\u2013 1562 .","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134555.59460.5D"},{"key":"e_1_3_9_33_2","first-page":"1164","article-title":"Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging","volume":"23","author":"Murata T","year":"2002","unstructured":"Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S . Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol 2002; 23: 1164\u2013 1172 .","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_9_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.6.803"},{"key":"e_1_3_9_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.02.067"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e31826d5fc3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T07:20:08Z","timestamp":1711524008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e31826d5fc3"}},"subtitle":["Report of the Guideline Development Subcommittee of the American Academy of Neurology"],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":34,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2012,10,2]]}},"alternative-id":["10.1212\/WNL.0b013e31826d5fc3"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e31826d5fc3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717957020.793461516","asserted-by":"object"}]},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]}}}